Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuHMFG1 in advanced breast cancer
NCT00066547Phase 2Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 2003
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bth1704 in breast cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: unknown.
02
Drugs
bth1704
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00066547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066547.